LLY241220P730000
- 1.15
- -0.78-40.41%
Eli Lilly and Co Newsroom
Lilly and EVA Pharma Announce Regulatory Approval and Release of Locally Manufactured Insulin in Egypt
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
Behind the Scenes of Eli Lilly's Latest Options Trends
The Stock Market Is One Big Contradiction Right -2-
Lilly Endowment Donates $10 Million for American Red Cross Service to the Armed Forces
Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com
Insurer Stocks Tumble. Trump Echoes Drug Industry Attacks on PBMs. -- Barrons.com
Moderna Remains the Most Shorted Among S&P 500 Healthcare Stocks in November
Express News | Trump: 'We're Going to Knock Out the Middlemen' Who Are Keeping Drug Prices High
Express News | Trump: Does Not Like Mandates for Vaccines, When Asked Whether Schools Should Mandate
Another Week, Another Index Record | Lkive Stock
Why the Investor Craze for Ozempic and Rival Weight-loss Drugs May Resume Next Year
The Weight-Loss Drug Market Is Heading for a Reckoning This Week -- Barrons.com
EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease
The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect
INNOVENT BIO (01801) has reached a commercialization cooperation with Eli Lilly and Co regarding a new cancer drug based on BTK inhibitors.
On December 16, INNOVENT BIO (01801) and Eli Lilly and Co jointly announced the following cooperation agreement regarding Eli Lilly's non-covalent (reversible) BTK inhibitor, Jaypalta (100 mg and 50 mg tablets), in mainland China: INNOVENT BIO will be responsible for the import, sales, promotion, and distribution of Jaypalta; Eli Lilly will be responsible for the research and development as well as post-marketing medical affairs related work.
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca (Pirtobrutinib) in Mainland China
Eli Lilly (NYSE:LLY) Is Increasing Its Dividend To $1.50
Why Is Eli Lilly and Company (LLY) Among the Best Income Stocks to Buy According to Analysts?
Weekly Buzz: Tech stocks hit high scores on ominous day